Arix Bioscience Plc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Arix Bioscience Plc with three other
companies in this sector in UNITED KINGDOM :
Shield Therapeutics PLC
(2019
sales of £719,000.00 [US$987,639.97 ]
of which 100%
was Feraccru),
Midatech Pharma PLC
(£674,000.00 [US$925,826.62 ]
of which 100%
was Pipeline R&D), and
Physiomics PLC
(£718,965.00 [US$987,591.89 ]
of which 100%
was Outsourced Systems and Computational Bio).
Sales Analysis.